Imaging lung lymphocytic infiltration with radiolabelled Interleukin-2 in the follow-up of patients with lung transplantation; a marker of acute rejectio

Phase 2

• Conditions: lung transplantation; acute rejection; 10013369

• Registration Number: NL-OMON33003
• Lead Sponsor: niversitair Medisch Centrum Groningen

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Last Update Posted: 6 May 2024

Recruitment & Eligibility

• Status: Pending
• Sex: Not specified
• Target Recruitment: 60

Inclusion Criteria

All patient with lung transplantation

Exclusion Criteria

Children, pregnant and lactating women

Study & Design

• Study Type: Observational invasive
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
<p>Evalution of IL-2 scan to detect acute rejection. Comparison between IL-2<br /><br>uptake and histopathological findings.</p><br>

Secondary Outcome Measures

Name	Time	Method
<p>Nvt</p><br>